Vanguard Group’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$93.4M Buy
4,703,040
+58,376
+1% +$1.12M ﹤0.01% 1904
2025
Q3
$84.8M Sell
4,644,664
-22,562
-0.5% -$371K ﹤0.01% 1928
2025
Q2
$73.5M Buy
4,667,226
+824,858
+21% +$10.5M ﹤0.01% 1956
2025
Q1
$48.7M Buy
3,842,368
+881
+0% +$13.8K ﹤0.01% 2102
2024
Q4
$84.6M Sell
3,841,487
-56,349
-1% -$1.18M ﹤0.01% 1939
2024
Q3
$69.5M Buy
+3,897,836
New +$62.5M ﹤0.01% 2044

Other funds holding CLMT

Vanguard Group's CLMT Position: Q4 2025 in Review

Vanguard Group increased its Calumet Specialty Products (CLMT) stake by 1.3% in Q4 2025, buying an estimated $1.12M and bringing the position to 4,703,040 shares worth $93.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Vanguard Group first reported a position in CLMT in Q3 2024 and has held it in 6 quarters since. 140 funds tracked by Wall St. Rank hold CLMT as of Q4 2025.

  • Vanguard Group held 4,703,040 shares of Calumet Specialty Products worth $93.4M as of Q4 2025.
  • Vanguard Group bought 58,376 Calumet Specialty Products shares in Q4 2025, an estimated $1.12M.
  • Calumet Specialty Products made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1904 holding.
  • Vanguard Group first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 6 quarters since.
  • 140 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.